Clinical Transfer of a Vulnerable Atherosclerotic Plaque Tracer : 99mTc-cAbVCAM1-5 (ATHENA)
Status:
Not yet recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
Clinical Transfer of a Tracer of the Vulnerable Atheroma Plate: 99mTc-cAbVCAM1-5. (ATHENA).
This is a phase I/IIa, prospective, monocentric, non-controlled, non-randomized, open-label,
interventional study.